nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—peripheral nervous system—type 1 diabetes mellitus	0.0443	0.236	CbGeAlD
Ingenol Mebutate—PRKCA—nerve—type 1 diabetes mellitus	0.0345	0.184	CbGeAlD
Ingenol Mebutate—PRKCD—lymphoid tissue—type 1 diabetes mellitus	0.0184	0.0983	CbGeAlD
Ingenol Mebutate—PRKCA—islet of Langerhans—type 1 diabetes mellitus	0.0167	0.0892	CbGeAlD
Ingenol Mebutate—PRKCA—retina—type 1 diabetes mellitus	0.0143	0.0762	CbGeAlD
Ingenol Mebutate—PRKCA—nephron tubule—type 1 diabetes mellitus	0.0135	0.0718	CbGeAlD
Ingenol Mebutate—PRKCA—cardiovascular system—type 1 diabetes mellitus	0.0121	0.0645	CbGeAlD
Ingenol Mebutate—PRKCA—kidney—type 1 diabetes mellitus	0.0118	0.0631	CbGeAlD
Ingenol Mebutate—PRKCA—pancreas—type 1 diabetes mellitus	0.0118	0.0627	CbGeAlD
Ingenol Mebutate—PRKCA—lymphoid tissue—type 1 diabetes mellitus	0.0102	0.0542	CbGeAlD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	0.000202	0.000249	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000202	0.000248	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000201	0.000248	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—IL6—type 1 diabetes mellitus	0.0002	0.000247	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—EGFR—type 1 diabetes mellitus	0.000199	0.000245	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—STAT3—type 1 diabetes mellitus	0.000199	0.000245	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000199	0.000244	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—EGFR—type 1 diabetes mellitus	0.000198	0.000244	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—EGFR—type 1 diabetes mellitus	0.000198	0.000244	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—TYK2—type 1 diabetes mellitus	0.000198	0.000243	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—EGFR—type 1 diabetes mellitus	0.000197	0.000243	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—VAV1—type 1 diabetes mellitus	0.000197	0.000242	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—TYK2—type 1 diabetes mellitus	0.000196	0.000242	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—IL6—type 1 diabetes mellitus	0.000196	0.000242	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—EGFR—type 1 diabetes mellitus	0.000196	0.000242	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000196	0.000241	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000196	0.000241	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HLA-DQB1—type 1 diabetes mellitus	0.000193	0.000237	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000189	0.000233	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000188	0.000232	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000188	0.000232	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—LGALS3—type 1 diabetes mellitus	0.000187	0.00023	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—VDR—type 1 diabetes mellitus	0.000186	0.000229	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD86—type 1 diabetes mellitus	0.000186	0.000229	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—EGFR—type 1 diabetes mellitus	0.000185	0.000227	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—EGFR—type 1 diabetes mellitus	0.000185	0.000227	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CD86—type 1 diabetes mellitus	0.000183	0.000225	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—EGFR—type 1 diabetes mellitus	0.000183	0.000225	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000183	0.000225	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—E2F1—type 1 diabetes mellitus	0.000182	0.000224	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD40LG—type 1 diabetes mellitus	0.000182	0.000224	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—IL2—type 1 diabetes mellitus	0.000182	0.000223	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—EGFR—type 1 diabetes mellitus	0.000181	0.000223	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—EGFR—type 1 diabetes mellitus	0.000181	0.000222	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00018	0.000222	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD8A—type 1 diabetes mellitus	0.00018	0.000222	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—STAT3—type 1 diabetes mellitus	0.00018	0.000222	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ITPR3—type 1 diabetes mellitus	0.000179	0.00022	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—IL2RA—type 1 diabetes mellitus	0.000178	0.000219	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000178	0.000219	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CD4—type 1 diabetes mellitus	0.000178	0.000219	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IFIH1—type 1 diabetes mellitus	0.000178	0.000218	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000177	0.000218	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000176	0.000217	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—CASP3—type 1 diabetes mellitus	0.000176	0.000216	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000174	0.000214	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HLA-B—type 1 diabetes mellitus	0.000173	0.000213	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SLC11A1—type 1 diabetes mellitus	0.000173	0.000213	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CD86—type 1 diabetes mellitus	0.000171	0.000211	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—IL6—type 1 diabetes mellitus	0.000171	0.000211	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—HLA-B—type 1 diabetes mellitus	0.000171	0.00021	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—IL6—type 1 diabetes mellitus	0.00017	0.00021	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—IL6—type 1 diabetes mellitus	0.000168	0.000207	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ERBB3—type 1 diabetes mellitus	0.000168	0.000206	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDK4—type 1 diabetes mellitus	0.000166	0.000204	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000166	0.000204	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SST—type 1 diabetes mellitus	0.000165	0.000203	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—ERBB3—type 1 diabetes mellitus	0.000165	0.000203	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ITPR3—type 1 diabetes mellitus	0.000165	0.000203	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—CASP3—type 1 diabetes mellitus	0.000165	0.000203	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000165	0.000203	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000164	0.000202	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—EGFR—type 1 diabetes mellitus	0.000164	0.000201	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—IL6—type 1 diabetes mellitus	0.000163	0.000201	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL2RA—type 1 diabetes mellitus	0.000162	0.0002	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PTPN2—type 1 diabetes mellitus	0.000162	0.0002	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000161	0.000198	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—B2M—type 1 diabetes mellitus	0.000161	0.000198	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HLA-A—type 1 diabetes mellitus	0.000161	0.000198	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00016	0.000197	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.000158	0.000195	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—IL6—type 1 diabetes mellitus	0.000158	0.000194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000158	0.000194	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ERBB3—type 1 diabetes mellitus	0.000155	0.00019	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—APOC3—type 1 diabetes mellitus	0.000154	0.00019	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IAPP—type 1 diabetes mellitus	0.000154	0.00019	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—IL6—type 1 diabetes mellitus	0.000153	0.000189	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CRP—type 1 diabetes mellitus	0.000153	0.000189	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—NOS2—type 1 diabetes mellitus	0.000153	0.000188	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—IL6—type 1 diabetes mellitus	0.000152	0.000188	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CCR5—type 1 diabetes mellitus	0.000152	0.000187	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000152	0.000187	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—IL6—type 1 diabetes mellitus	0.000152	0.000187	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CRP—type 1 diabetes mellitus	0.000151	0.000186	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—IL6—type 1 diabetes mellitus	0.000151	0.000186	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDK4—type 1 diabetes mellitus	0.000149	0.000183	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HLA-A—type 1 diabetes mellitus	0.000148	0.000182	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—B2M—type 1 diabetes mellitus	0.000148	0.000182	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000147	0.000181	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000147	0.000181	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000147	0.000181	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HLA-DRB1—type 1 diabetes mellitus	0.000147	0.000181	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000143	0.000176	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—IL6—type 1 diabetes mellitus	0.000142	0.000175	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—IL6—type 1 diabetes mellitus	0.000142	0.000175	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HLA-DPB1—type 1 diabetes mellitus	0.000142	0.000175	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000142	0.000175	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—IL6—type 1 diabetes mellitus	0.000141	0.000173	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HLA-E—type 1 diabetes mellitus	0.00014	0.000172	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—IL6—type 1 diabetes mellitus	0.000139	0.000172	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—IL6—type 1 diabetes mellitus	0.000139	0.000171	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000139	0.00017	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—STAT3—type 1 diabetes mellitus	0.000138	0.00017	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ITPR3—type 1 diabetes mellitus	0.000138	0.00017	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000138	0.00017	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000138	0.00017	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000137	0.000169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000137	0.000169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000137	0.000169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—IGF1—type 1 diabetes mellitus	0.000136	0.000167	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD80—type 1 diabetes mellitus	0.000136	0.000167	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CTLA4—type 1 diabetes mellitus	0.000135	0.000166	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000134	0.000165	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CD80—type 1 diabetes mellitus	0.000134	0.000164	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000134	0.000164	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—HBA1—type 1 diabetes mellitus	0.00013	0.00016	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—APOC3—type 1 diabetes mellitus	0.000129	0.000159	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NOS2—type 1 diabetes mellitus	0.000129	0.000159	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000129	0.000158	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—ALB—type 1 diabetes mellitus	0.000129	0.000158	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD79A—type 1 diabetes mellitus	0.000128	0.000158	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GSTT1—type 1 diabetes mellitus	0.000127	0.000156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PRKCQ—type 1 diabetes mellitus	0.000126	0.000155	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—EGFR—type 1 diabetes mellitus	0.000126	0.000155	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	0.000126	0.000155	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000125	0.000154	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CD80—type 1 diabetes mellitus	0.000125	0.000154	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—EGFR—type 1 diabetes mellitus	0.000125	0.000154	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000125	0.000153	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOS1—type 1 diabetes mellitus	0.000124	0.000153	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—NOS3—type 1 diabetes mellitus	0.000123	0.000151	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—VAV1—type 1 diabetes mellitus	0.000122	0.000151	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000122	0.00015	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CD86—type 1 diabetes mellitus	0.00012	0.000148	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HLA-DQA1—type 1 diabetes mellitus	0.000118	0.000146	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—INS—type 1 diabetes mellitus	0.000118	0.000145	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PRKCQ—type 1 diabetes mellitus	0.000116	0.000143	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000116	0.000142	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000115	0.000141	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—TYK2—type 1 diabetes mellitus	0.000114	0.000141	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000114	0.00014	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000114	0.00014	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—VAV1—type 1 diabetes mellitus	0.000113	0.000139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—TYK2—type 1 diabetes mellitus	0.000113	0.000139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000112	0.000138	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HLA-DQB1—type 1 diabetes mellitus	0.000111	0.000136	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000109	0.000134	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000108	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000108	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000108	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IFNG—type 1 diabetes mellitus	0.000107	0.000132	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—VDR—type 1 diabetes mellitus	0.000107	0.000132	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD86—type 1 diabetes mellitus	0.000107	0.000131	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000107	0.000131	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TYK2—type 1 diabetes mellitus	0.000106	0.00013	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000105	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD40LG—type 1 diabetes mellitus	0.000105	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—IL2—type 1 diabetes mellitus	0.000104	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000104	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NOS3—type 1 diabetes mellitus	0.000104	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000104	0.000127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD8A—type 1 diabetes mellitus	0.000103	0.000127	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD4—type 1 diabetes mellitus	0.000103	0.000127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000102	0.000126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CD4—type 1 diabetes mellitus	0.000102	0.000126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GCG—type 1 diabetes mellitus	0.000101	0.000125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HLA-B—type 1 diabetes mellitus	9.95e-05	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CD86—type 1 diabetes mellitus	9.85e-05	0.000121	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—IL6—type 1 diabetes mellitus	9.67e-05	0.000119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ERBB3—type 1 diabetes mellitus	9.62e-05	0.000118	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—IL6—type 1 diabetes mellitus	9.61e-05	0.000118	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL1B—type 1 diabetes mellitus	9.55e-05	0.000118	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CD4—type 1 diabetes mellitus	9.55e-05	0.000118	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL2—type 1 diabetes mellitus	9.52e-05	0.000117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SST—type 1 diabetes mellitus	9.49e-05	0.000117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ADRB1—type 1 diabetes mellitus	9.45e-05	0.000116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL2RA—type 1 diabetes mellitus	9.33e-05	0.000115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HLA-A—type 1 diabetes mellitus	9.22e-05	0.000113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ERBB3—type 1 diabetes mellitus	8.88e-05	0.000109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CRP—type 1 diabetes mellitus	8.8e-05	0.000108	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CD80—type 1 diabetes mellitus	8.76e-05	0.000108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CCR5—type 1 diabetes mellitus	8.74e-05	0.000108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CAT—type 1 diabetes mellitus	8.57e-05	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HLA-A—type 1 diabetes mellitus	8.51e-05	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GCG—type 1 diabetes mellitus	8.46e-05	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HLA-DRB1—type 1 diabetes mellitus	8.42e-05	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—INS—type 1 diabetes mellitus	8.28e-05	0.000102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	8.14e-05	0.0001	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—STAT3—type 1 diabetes mellitus	8.01e-05	9.86e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.01e-05	9.86e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.97e-05	9.81e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VAV1—type 1 diabetes mellitus	7.91e-05	9.74e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CXCL10—type 1 diabetes mellitus	7.89e-05	9.71e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD80—type 1 diabetes mellitus	7.78e-05	9.58e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOS2—type 1 diabetes mellitus	7.41e-05	9.12e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.4e-05	9.1e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—STAT3—type 1 diabetes mellitus	7.4e-05	9.1e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EGFR—type 1 diabetes mellitus	7.28e-05	8.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.26e-05	8.94e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—TYK2—type 1 diabetes mellitus	7.19e-05	8.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CD80—type 1 diabetes mellitus	7.19e-05	8.84e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EGFR—type 1 diabetes mellitus	7.18e-05	8.84e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IGF2—type 1 diabetes mellitus	7.16e-05	8.82e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CD86—type 1 diabetes mellitus	6.9e-05	8.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—INS—type 1 diabetes mellitus	6.79e-05	8.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EGFR—type 1 diabetes mellitus	6.72e-05	8.27e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—IL2—type 1 diabetes mellitus	6.59e-05	8.11e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—TYK2—type 1 diabetes mellitus	6.57e-05	8.09e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.55e-05	8.06e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.22e-05	7.66e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.16e-05	7.59e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL2—type 1 diabetes mellitus	6.15e-05	7.57e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IFNG—type 1 diabetes mellitus	6.15e-05	7.57e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.12e-05	7.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCR5—type 1 diabetes mellitus	6.12e-05	7.53e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TYK2—type 1 diabetes mellitus	6.07e-05	7.47e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.03e-05	7.42e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.98e-05	7.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOS3—type 1 diabetes mellitus	5.95e-05	7.33e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD4—type 1 diabetes mellitus	5.94e-05	7.31e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—INS—type 1 diabetes mellitus	5.69e-05	7e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL6—type 1 diabetes mellitus	5.59e-05	6.89e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IL6—type 1 diabetes mellitus	5.52e-05	6.79e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL1B—type 1 diabetes mellitus	5.49e-05	6.75e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CD4—type 1 diabetes mellitus	5.49e-05	6.75e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL2—type 1 diabetes mellitus	5.47e-05	6.73e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ALB—type 1 diabetes mellitus	5.21e-05	6.42e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.18e-05	6.37e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IL6—type 1 diabetes mellitus	5.17e-05	6.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CD80—type 1 diabetes mellitus	5.03e-05	6.19e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—NOS3—type 1 diabetes mellitus	4.99e-05	6.14e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—INS—type 1 diabetes mellitus	4.75e-05	5.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.71e-05	5.79e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—STAT3—type 1 diabetes mellitus	4.6e-05	5.66e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.6e-05	5.66e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.58e-05	5.63e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.25e-05	5.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—STAT3—type 1 diabetes mellitus	4.25e-05	5.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EGFR—type 1 diabetes mellitus	4.18e-05	5.15e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.17e-05	5.13e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EGFR—type 1 diabetes mellitus	3.86e-05	4.75e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL6—type 1 diabetes mellitus	3.62e-05	4.45e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.54e-05	4.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL2—type 1 diabetes mellitus	3.53e-05	4.35e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.52e-05	4.33e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL6—type 1 diabetes mellitus	3.21e-05	3.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.97e-05	3.66e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IL6—type 1 diabetes mellitus	2.97e-05	3.65e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.7e-05	3.33e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL6—type 1 diabetes mellitus	2.08e-05	2.56e-05	CbGpPWpGaD
